Modeling predicts that CRISPR-based activators, unlike CRISPR-based repressors, scale well with increasing gRNA competition and dCas9 bottlenecking: Difference between revisions
From Murray Wiki
Jump to navigationJump to search
(Created page with "{{Paper |Title=Modeling predicts that CRISPR-based activators, unlike CRISPR-based repressors, scale well with increasing gRNA competition and dCas9 bottlenecking |Authors=Sam...") |
No edit summary |
||
| Line 8: | Line 8: | ||
|ID=2019g | |ID=2019g | ||
|Tag=CM19-biorxiv | |Tag=CM19-biorxiv | ||
|Flags=Biocircuits | |Flags=Biocircuits | ||
}} | }} | ||
Revision as of 14:33, 12 September 2021
| Title | Modeling predicts that CRISPR-based activators, unlike CRISPR-based repressors, scale well with increasing gRNA competition and dCas9 bottlenecking |
|---|---|
| Authors | Samuel Clamons and Richard Murray |
| Source | bioRxiv preprint |
| Abstract | Synthetic transcriptional networks built from CRISPR-based repressors (CRISPRi) rely on shared use of a core dCas9 protein. In E. coli, CRISPRi cannot support more than about a dozen simultaneous gRNAs before the fold repression of any individual gRNA drops below 10x. We show with a simple model based on previous characterization of competition in CRISPRi that activation by CRISPR-based activators (CRISPRa) is much less sensitive to dCas9 bottle-necking than CRISPRi. We predict that E. coli should be able to support dozens to hundreds of CRISPRa gRNAs at >10-fold activation. |
| Type | Preprint |
| URL | https://www.biorxiv.org/content/10.1101/719278v2 |
| DOI | |
| Tag | CM19-biorxiv |
| ID | 2019g |
| Funding | |
| Flags | Biocircuits |
